Arvest Investments’s Merck MRK Stock Holding History

Arvest Investments’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.96M	Buy	30,803 +2,198	+8%	+$257K	0.48%	50
2026 Q1	$3.44M	Sell	28,605 -2,655	-8%	-$307K	0.47%	49
2025 Q4	$3.29M	Sell	31,260 -1,710	-5%	-$161K	0.46%	48
2025 Q3	$2.77M	Sell	32,970 -7,033	-18%	-$579K	0.4%	51
2025 Q2	$3.17M	Sell	40,003 -5,313	-12%	-$422K	0.48%	49
2025 Q1	$4.07M	Buy	45,316 +6,765	+18%	+$632K	0.64%	37
2024 Q4	$3.84M	Buy	38,551 +11	+0%	+$1.13K	0.61%	38
2024 Q3	$4.38M	Buy	38,540 +1,367	+4%	+$162K	0.66%	37
2024 Q2	$4.6M	Sell	37,173 -378	-1%	-$48.7K	0.74%	33
2024 Q1	$4.95M	Sell	37,551 -5,757	-13%	-$710K	0.79%	30
2023 Q4	$4.72M	Buy	+43,308	New	+$4.5M	0.77%	30

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Arvest Investments's MRK Position: Q2 2026 in Review

Arvest Investments increased its Merck (MRK) stake by 7.7% in Q2 2026, buying an estimated $257K and bringing the position to 30,803 shares worth $3.96M. The position accounts for 0.48% of the portfolio, ranked #50.

Arvest Investments first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.95M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Arvest Investments held 30,803 shares of Merck worth $3.96M as of Q2 2026.
Arvest Investments bought 2,198 Merck shares in Q2 2026, an estimated $257K.
Merck made up 0.48% of Arvest Investments's portfolio in Q2 2026, its #50 holding.
Arvest Investments first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
Arvest Investments's Merck position peaked at $4.95M in Q1 2024.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Arvest Investments's 13F filing for Q2 2026, filed 17 Jul 2026.